Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Ähnliche Einträge

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  von: Mukhtyar, C, et al.
  Veröffentlicht: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  von: Mukhtyar, C, et al.
  Veröffentlicht: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  von: Saket Jha, et al.
  Veröffentlicht: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  von: Zhi-Ying Li, et al.
  Veröffentlicht: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  von: Mahmoud M. Mohamed, et al.
  Veröffentlicht: (2023-07-01)